Nutriband, Inc. Stock Plummets to New 52-Week Low of $3.28

Nutriband, Inc., a microcap player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 3.28 as of May 28, 2026. This significant decline highlights ongoing challenges for the company, which has seen its stock price drop substantially from its 52-week high of USD 11.68. Over the past year, Nutriband has reported a return of -43.48%, underperforming the S&P 500, which has seen a performance increase of 28.45% during the same period. The company's financial metrics reflect a difficult operating environment, with net sales for the half-year at USD 0.75 million, down 42.03% year-over-year. Additionally, Nutriband reported a net profit loss of USD 4.84 million, a decline of 47.4%. The company's return on equity stands at a negative 121.64%, indicating significant inefficiencies in management. With a market capitalization of USD 46 million and a price-to-book ratio of 6.13, Nutriband's financial health remains a concern as it navigates these challenging market conditions.